Eleven patients have died while taking Alzheimer's disease drug Aricept during a clinical trial, Japan's Eisai Co., which makes the medicine, said on Thursday.
There were no deaths among patients who were taking a placebo, said Eisai, which markets Aricept with Pfizer Inc.
Thursday, March 16, 2006
Science!
The beauty of science is that it sometimes provides you with incontrovertible evidence.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment